ISCB
iShares Morningstar Small-Cap ETF
SMB
Adj. R2
0.972
Rel. Sharpe
0.793
Mkt beta
1.02
AUM
US$261M
MER
0.04%
Valuation
102
ETF comparison
Verified factor-similar pair
ISCB vs UPGD
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
Similarity score
91
Near substitute
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- ISCB has the higher backtested relative Sharpe (0.793 vs 0.583).
- ISCB has the lower published fee (0.04% vs 0.40%).
- UPGD is cheaper on dividend valuation (64 vs 102, where 100 is each fund's historical median).
- ISCB has the stronger regression fit (adjusted R-squared 0.972 vs 0.880).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
UPGD
Invesco Bloomberg Analyst Rating Improvers ETF
SMB
Adj. R2
0.880
Rel. Sharpe
0.583
Mkt beta
1.06
AUM
US$110M
MER
0.40%
Valuation
64
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff +0.10
HML
diff +0.07
RMW
diff -0.04
CMA
diff -0.03
UMD
diff +0.03
Why This Pair Matches
Exposure level
90
Exposure shape
100
Mkt beta diff
0.04
Rel. Sharpe diff
0.209
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.